Renal mass biopsy in the management of kidney cancer

A review of the evolving field of the management of renal masses has been published in the Canadian Urological Association Journal. In this review, an expert panel from the Kidney Cancer Research Network of Canada provided the following recommendations: Renal mass biopsy should be offered to patients if the results of the biopsy will change […]

read more

Potential urine biomarkers for small renal masses

A recent study, published in the International Journal of Urology, has identified two potential biomarkers for the presence of malignant small renal masses in the urine. The study investigated aquaporin 1 and perilipin 2 to determine if these biomarkers were predictive of malignancy. During the study with 57 patients, the presence of aquaporin 1 and […]

read more

Biopsy of small renal massess

The question as to whether to biopsy small renal masses or not is debated by two kidney cancer experts; Professor Jaime Landman from University of California Irvine Medical Centre in the US, and Professor Michael Staehler from the Ludwig- Maximilian University in Munich, Germany.  The experts discuss whether patients with small renal masses should be […]

read more

Biopsy of small renal masses – still controversial?

Dr Finelli from the Princess Margaret Cancer Centre in Toronto, Canada, gave a presentation in favour of the biopsy of small renal masses at the Canadian Uro-oncology Summit in Toronto last week. In summary, a renal tumour biopsy is accurate, safe, impacts management, avoids over-treatment and enables personalised care for each patient. Dr Finelli recommends […]

read more

MD Anderson Cancer Center 13th Update on the Management of Genitourinary Malignancies Conference

The MD Anderson Cancer Center (MDACC) 13th Update on the Management of Genitourinary Malignancies Conference took place in Houston, Texas at the end of last week (9-10 November). Kidney cancer highlights from the meeting have been published by UroToday. You can read more online on UroToday below: MDACC 2018: Promising Emerging Systemic Therapies for mRCC MDACC […]

read more

Renal biopsy has a low risk of cancer spread to the fat surrounding the kidney

A recent study has shown that the risk of spread of cancer cells to the fat surrounding the kidney (perinephric fat) during a biopsy for renal cell carcinoma (RCC) is very small, and occurred in only 1.2% of cases. In these cases, a renal mass biopsy resulted in the stage of the cancer changing from […]

read more

Liquid biopsies: new test assesses proteins in the blood for early detection of cancer

Liquid biopsies have shown to be a non-invasive test for the detection of advanced cancer by measuring the levels circulating tumour DNA (ctDNA) in the blood of cancer patients. Much of the published research uses ctDNA for the detection of advanced tumours; however, detection of early-stage tumours has proven more difficult. Liquid biopsies also have […]

read more

Liquid biopsy for renal cell carcinoma

A recent study presented at the American Urology Association (AUA) Annual Meeting in Boston last month, described the concept of using tumour DNA that is circulating in the blood stream as a novel biomarker for the diagnosis and surveillance of renal cancer. The collection of tumour DNA from blood is relatively easy and non-invasive; an advantage over […]

read more

Barriers to biopsy of small renal masses

A recent survey of Canadian Urologists assessed the use of renal tumour biopsy in the management of small renal masses and identified barriers to a more widespread use of renal tumour biopsy. Renal tumour biopsy has been demonstrated to be a safe procedure, and without the perceived risk of spreading the cancer cells throughout the […]

read more
Showing all 9 results
  TOP